With respect to the duration of the intervention study and the rapid turnover of SELENOP [14,47], it is unlikely that the elevated SELENOP level is related to a release of the protein from the endothelium in our case, however, this possibility cannot be excluded either, especially when considering the fact that our study participants were chosen for their elevated risk of cardiovascular diseases. Here, SELENOP is linked to cardiovascular disorder.